AbbVie
ABBV
$291.57
Share price
3.39%
Change (1 day)
12.89%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
AbbVie (ABBV) - Net assets
Net assets on the balance sheet as of December 2024 : A$5.25 Billion
According to AbbVie's latest financial reports the company has A$5.25 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
AbbVie - Net assets on balance sheet (from 2011 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $A$5.40 B | -64.56% |
| 2023-12-31 | $A$15.26 B | -39.93% |
| 2022-12-31 | $A$25.40 B | 19.31% |
| 2021-12-31 | $A$21.29 B | 25% |
| 2020-12-31 | $A$17.03 B | -245.93% |
| 2019-12-31 | $-A$11.68 Billion | -2.65% |
| 2018-12-31 | $-A$11.99 Billion | -283.64% |
| 2017-12-31 | $A$6.52 B | 1.51% |
| 2016-12-31 | $A$6.43 B | 18.77% |
| 2015-12-31 | $A$5.41 B | 154.41% |
| 2014-12-31 | $A$2.12 B | -57.73% |
| 2013-12-31 | $A$5.03 B | 55.62% |
| 2012-12-31 | $A$3.23 B | -72.19% |
| 2011-12-31 | $A$11.63 B | -24.72% |
| 2010-12-31 | $A$15.45 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | A$138.36 B | 2,530.71% | 🇺🇸 USA |
 | A$25.62 B | 387.16% | 🇺🇸 USA |
 | A$22.31 B | 324.24% | 🇺🇸 USA |
 | A$9.18 B | 74.70% | 🇺🇸 USA |
 | A$30.09 B | 472.12% | 🇺🇸 USA |
 | A$26.13 B | 396.91% | 🇺🇸 USA |
 | A$25.67 B | 388.16% | 🇬🇧 UK |
 | A$63.90 B | 1,114.95% | 🇬🇧 UK |
 | A$4.04 B | -23.02% | 🇺🇸 USA |